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The physical stability is crucial in formulating liposomes for drug delivery applications. The 
objective of the present study was to develop and evaluate the electrospun amphiphilic 
nanofibers intended for the templates and delivery of drug-loaded liposomes. This approach 
exploits the hydration of phospholipids deposited on electrospun nanofibers for the 
formation of liposomes, and the strategy was recently introduced in the literature for non-
pharmaceutical applications. The present study was carried out in 2014-2015 as a research 
collaboration between Department of Pharmacy, Faculty of Health Sciences, University of 
Tromsø The Arctic University of Norway, Norway and Department of Pharmacy, Faculty of 
Medicine, University of Tartu, Estonia. 
 
The drug-loaded amphiphilic nanofibers were prepared by using a ESR200RD robotized 
electrospinning system (NanoNC, Korea). Polyvinylpyrrolidone (PVP 90) and soybean 
phosphatidylcholine (PC) were used at different concentrations as a filament-forming matrix. 
Chloramphenicol (CAM) was used at different concentrations as a model drug. The liposome 
formation was monitored in situ by using optical microscopy. The geometric properties and 
surface topography of nanofibers were characterized by scanning electron microscopy 
(SEM). Particle size of liposomes was measured by photon correlation spectroscopy (PCS). 
Rhodamine-labelled nanofiber-hydrated liposomes were examined using fluorescence 
microscopy. Drug encapsulation efficiency was determined by using high performance liquid 
chromatography (HPLC).  
 
Electrospinning of PC with PVP using ethanol as a solvent was found to be successful in 
fabricating drug-loaded amphiphilic composite nanofibers. According to the optical 
microscopy results, the immediate hydration of phospholipids deposited on the amphiphilic 
nanofibers occurred within few seconds resulting in the formation of liposomes in water. 
The liposomes appeared to aggregate more readily in the concentrated solutions than in the 




useful techniques to illustrate the formation of liposomes. HPLC analysis indicated that the 
drug entrapment efficiency varied when different CAM concentrations were used.  
 
In conclusion, it is possible to prepare drug-loaded liposomes in situ using the hydration of 
phospholipids deposited on the electrospun amphiphilic nanofibers. The present 
nanotechnology self-assembly approach opens up new options for the fabrication, 









Den fysikalske stabiliteten er essensiell i formulering av liposomer for bruk innen drug 
delivery. Hensikten med denne studien var å utvikle og evaluere elektrospunnete nanofibre 
tiltenkt som templat i produksjon av liposomer med inkorporert virkestoff. Denne metoden, 
nylig introdusert i litteraturen for ikke-farmasøytiske applikasjoner, benytter hydrering av 
fosfolipider avsatt på elektrospunnete nanofibre for å danne liposomer. Studien som danner 
grunnlag for denne masteroppgaven ble utført i 2014-2015 som et vitenskapelig samarbeid 
mellom Institutt for farmasi, Det helsevitenskapelige fakultet, Universitetet i Tromsø, Norges 
arktiske universitet, Norge og Department of Pharmacy, Faculty of Medicine, University of 
Tartu, Estland.  
 
De amfifile nanofibrene med virkestoff ble dannet ved hjelp av et ESR200RD robotisert 
elektrospinningsystem (NanoNC, Korea). Polyvinylpyrrolidon (PVP 90) og fosfatidylkolin 
isolert fra soyabønner (PC) ble brukt i forskjellige konsentrasjoner som en filament-
formende matriks. Kloramfenikol (CAM) ble tilsatt i varierende konsentrasjoner som 
modellsubstans. De liposomale formuleringene ble monitorert in situ ved bruk av 
lysmikroskopi. De geometriske egenskapene og overflatetopografien til nanofibrene ble 
karakterisert ved hjelp av scanning electron microscopy (SEM). Partikkelstørrelsen til 
liposomene ble målt ved hjelp av fotonkorrelasjonspektroskopi (PCS). Rodamin-merkede 
nanofiber-hydrerte liposomer ble undersøkt med fluorosensmikroskopi. Inkorporeringsgrad 
av virkestoff ble bestemt ved hjelp av high performance liquid chromatography (HPLC).  
 
Elektrospinning av PVP og PC oppløst i etanol resulterte i vellykket produksjon av amfifile 
nanofibre med virkestoff. I følge resultatene fra lysmikroskopi inntraff den umiddelbare 
hydreringen av fosfolipidene på de amfifile nanofibrene i løpet av få sekunder og resulterte i 
dannelse av liposomer. Liposomene hadde en større tendens til å aggregere i de 
konsentrerte dispersjonene sammenlignet med de fortynnede dispersjonene. Rodamin-
merking sammen med fluorosensmikroskopi var en nyttig metode for å illustrere 
formasjonen av liposomer. HPLC-analysene viste at inkorporering av virkestoff varierte med 





Det kan dermed konkluderes med at det er mulig å danne liposomer med inkorporert 
virkemiddel in situ ved hjelp av fosfolipider avsatt på elektrospunnete amfifile nanofibre. 
Denne studien åpner nye muligheter for produksjon, stabilisering og delivery av liposomer 
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Spherical vesicles composited of phospholipids with an aqueous core, also known as 
liposomes, have played a big part in nanomedicine drug delivery research and product 
development. One of the biggest challenges when it comes to liposome preparation is to get 
a product which has a monodisperse population, even vesicle sizes and a decent stability (Yu 
et al., 2009).  
 
Recently, Yu and coworkers (2012) prepared for the first time ever monodisperse liposomes 
by hydrating phospholipids deposited on electrospun amphiphilic nanofibers, composed of 
the hydrophilic polymer polyvinylpyrrolidone (PVP) and phosphatidylcholine (PC) (Yu et al., 
2012). The templating and confinement properties of the nanofibers enabled spontaneous 
self-assembly of phosphatidylcholine, and liposomes were formed.  
 
To date, liposomes self-assembled from hydrated amphiphilic nanofibers have not been 
exploited to fabricate drug-loaded liposomes, nor compared to any conventional liposome 
preparation methods. 
 
The main aim of the present thesis was to find out whether it is possible to prepare the 
drug-loaded liposomes using a novel strategy based on the hydration of phospholipids 
deposited on electrospun amphiphilic nanofibers. In addition, the goal of the work was to 














2.1.1 Definition and background 
Liposomes are spherical vesicles consisting of an aqueous core surrounded by one (Fig. 1) or 
several phospholipid bilayers. They are small in size, ranging from 50 nm to approximately 1 
µm and larger (Banerjee, 2001). Liposomes are used as drug delivery vehicles, among other 
applications. When loading the liposomes with drug, hydrophilic molecules will be 
entrapped in the core of the spherical vesicle, while lipophilic drug molecules mainly will be 




Figure 1. A single-lamellar liposome and a phospholipid molecule, which is the bilayers building block. The pink head of the 
phospholipid molecule illustrate the polar part, while the two blue tails illustrate the lipophilic part. Illustration: 
Encyclopædia Britannica, Inc., 2007. 
 
Phospholipids self-assemble into liposomes when they are hydrated to avoid the lipophilic 
parts of the molecule to get in contact with water. The properties of liposomes can be 
manipulated by using different types of phospholipids in the bilayer, and/or by changing the 
surface charge, liposome size and liposome preparation (Vemuri and Rhodes, 1995). The 




in our bodies (e.g. osmotic swelling, ion discrimination), thus liposomes can serve as a good 
model for human cell membranes (Fig. 2) (Sessa and Weissmann, 1968, Chatterjee and 
Agarwal, 1988).  
   
 
Figure 2. A schematic representation of phospholipid bilayer. The phospholipid molecules are assembled as the lipid bilayer 
in both liposomes and the human cell membranes. llustration: Encyclopædia Britannica, Inc., 2007. 
 
2.1.2 Phospholipids 
Phospholipids are a group of lipids containing groups of phosphoric acid. One of the main 
groups of phospholipids is lecithin, which is commonly found in plants and animals, e.g. in 
eggs (Store Norske Leksikon, 2009).  
 
Phospholipids are naturally occurring amphiphilic lipids. They have the ability to form lipid 
bilayers, partly due to their amphiphilic properties, and are an important constituent of the 
cell membranes in our body (Singer and Nicolson, 1972) 
 
Phosphatidylcholine (PC) was first mentioned in 1847 as a component of egg yolk, and at 
that time named lecithin (Cole et al., 2012). Under today’s definition, lecithin is a mixture of 
a variety of phospholipids and one of these lipids is PC (Martindale, 2013), but the name 
lecithin is still sometimes used as a synonym. 
 
PC consists of a glycerol backbone with three groups attached to it (Fig. 3). Two of these are 




phosphodiester linkage. The length and double bonding of the fatty acyl chains will vary in 
different PC molecules (Cole et al., 2012).  
 
 
Figure 3. The chemical structure of a phosphatidylcholine (PC) molecule. The glycerol backbone is marked grey, while the 
choline is blue and the fatty acyl chains are marked orange. Figure from Purves et al., 2003: Life, Science of Biology, Sixth 
Edition, by Sinauer Associates, Inc. 
 
2.1.3 Classification of liposomes 
Liposomes are classified according to a wide variety of factors – like their size, lamellarity, 
application, surface charge and production method. In this section, the main focus is on size, 
lamellarity and surface properties.  
 
There are three different classes of liposomes divided based on their size and lamellarity 
(Banerjee, 2001) (Fig. 4): 
1. Small unilamellar vesicles (SUV), with one lipid bilayer and diameter size 25-100 nm; 
2. Large unilamellar vesicles (LUV), with one lipid bilayer and diameter size 100-1000 
nm; 







Figure 4. The three main types of liposome classes and their size range given in diameter (nm). Small unilamellar vesicles 
(SUV) are the smallest liposomes, consisting of one bilayer and with a diameter ranging from 25-100 nm. Large unilamellar 
vesicles (LUV) have the same structure, but are a bit larger: 100-1000 nm. There are two types of large multilamellar vesicles 
(MLV) depending on how the bilayers are arranged inside the outer shell. MLV’s are the biggest group of liposomes, 1000 
nm and larger. 
 
Liposomes can also be classified based on their surface properties, and this type of 
classification is naturally more commonly used when dealing with liposomes for in vivo use. 
The way it is possible to manipulate the surface of liposomes gives them a great advantage 
when compared to the other colloidal drug delivery systems (Storm and Crommelin, 1998).  
 
There are four main groups:   
1. Conventional liposomes. Typically made from phospholipids and/or cholesterol. They 
can be neutral or negatively charged. Their size and lamellarity (Fig. 4) can easily be 
manipulated. Even though these conventional liposomes can be prepared differently, 
they still have about the same characteristics when injected into the bloodstream. 
They tend to accumulate and are broken down in the mononuclear phagocyte 
system (MPS), which makes the blood circulation time short compared to other 
liposomes.  
2. Long-circulating liposomes. These liposomes are made so that they will be circulating 
in the bloodstream for a relatively longer time before being taken up by the MPS. 
The most common way of making long-circulating liposomes is by covalently 
attaching hydrophilic polymer polyethylene glycol (PEG) on the outside of the lipid 




3. Immunoliposomes. They have antibodies or antibody fragments attached to their 
shell. These liposomes can be combined with PEGylation to increase the time of 
circulation in the bloodstream.  
4. Cationic liposomes. These liposomes have advantages when it comes to the delivery 
of genetic material. The positively charged surface interacts and neutralizes 
negatively charged DNA (Storm and Crommelin, 1998).  
 
 
Figure 5. Illustration showing a non-PEGylated and a PEGylated surface of a liposome. 
 
2.1.4 Characterization of liposomes 
Liposome physiochemical properties like lamellarity, surface charge, shape and size are very 
much influencing the behavior of the vesicles, e.g. how rapidly they are cleared from the 
bloodstream (Juliano and Stamp, 1975) . Characterization of the liposomes is important to 
understand and predict how the liposomes will act in prospective applications.  
 
Photon correlation spectroscopy (PCS) is a powerful analytical technique that can be used to 
determine the vesicle size and size distribution of a liposome dispersion. The PCS shows an 
insensitivity towards very small vesicles (<30 nm) if larger particles are present in the 
sample, and therefor is most often used combined with a size reduction of the liposomes 
prior to analysis (Ingebrigtsen and Brandl, 2002).  
 
Microscopic characterization methods like atomic force microscopy (AFM), environmental 




laser scanning microscopy (CLSM) can be used to study the shape, morphology, dimensions, 
surface properties and internal structure of the liposomes. Scanning electron microscopy 
(SEM) requires the sample to be dried or fixed before imaging, thus this is not an applicable 
method for the characterization of liposomes due to risk of liposomal damage (Karn et al., 
2013).  
 
The way the liposomes encapsulate drug, how the drug is released and the intracellular fate 
of the liposomes are all factors affected by the liposome lamellarity. Phosphorous-31 nuclear 
magnetic resonance  (13P-NMR) spectroscopy is a widely spread method used to characterize 
the liposomes which shows how many phospholipid bilayers the liposomes have and how 
they are arranged compared to each other (Fröhlich et al., 2001).  
 
The amount of drug which is trapped inside the aqueous core or the lipid bilayer of the 
liposomes is commonly calculated using a high performance liquid chromatography (HPLC). 
Drug encapsulation efficiency can be determined by using HPLC and analyzing how much 
drug that has been trapped inside the vesicles compared to the amount of drug which has 
not been encapsulated (Edwards and Baeumner, 2006). 
 
2.1.5 Liposome preparation methods 
There are many different ways of producing liposomes, and the method used can affect the 
properties of the liposomal product. Encapsulation efficiency is one example of a property 
that could be influenced by the production method, as shown by Liang and coworkers. In 
their study, they concluded that by preparing the liposomes by freeze-dried monophase 
systems hydration method, they were able to entrap a higher amount of lipopeptides than if 
they hydrated dried lipid films (Liang et al., 2005). 
  
There are a variety of different ways to produce the liposomes, and these can be categorized 
into two major groups (Patil and Jadhav, 2014): 
1. Transferring of phospholipids in an organic phase into an aqueous phase to produce 




2. Depositing of a thin lipid film on a substrate and subsequently hydrate to form 
liposomes  known as film methods. 
 
2.1.5.1 Conventional hydration of a phospholipid film 
The oldest and most common way of preparing liposomes is a thin-film hydration method.  It 
is a simple method which does not require any advance equipment, and this is why it is so 
frequently used. Lipids are dispersed in an organic solvent in a round bottom flask, and the 
solvent is evaporated using a rotary evaporator with a lowered pressure. The dry thin-film 
deposited on the inside of the flask is hydrated and liposomes self-assemble (Fig. 6). Like 
most conventional methods, this normally yields a dispersion containing liposomes of 
heterogeneous size and shape, and thus a size reduction technique is a common next step 
(Laouini et al., 2012).  
 
 
Figure 6. The basic principle of a thin-film hydration method: a) Lipid and organic solvent are mixed together in a round 
bottom flask; b) Solvent is evaporated and remaining is a thin lipid film deposited on the inside of the flaks; c) Water, often 
in the form of a buffer, is added and the flask is shaken; d) The thin film is hydrated and a heterogeneous dispersion of 
liposomes are self-assembled. 
  
2.1.5.2 Microfluidics method – thin film hydration  
Microfluidics is the technology, which allows performing fluid procedures in a very small 
geometrically constrained volume. This relatively new technology opens a number of 
possibilities when combined with other scientific knowledge. One example is the fabrication 






Microfluidics is a very versatile method, which makes it possible to produce liposomes 
ranging from tens of nanometer to tens of micrometers in diameter (Yu et al., 2009).                                                                                                                                                                                                                                                      
 
2.1.6 Liposomes as drug delivery system 
Liposomes have been extensively used in pharmaceutical applications and they show a great 
amount of favorable properties as drug delivery systems. They offer metabolic protection of 
the drug, higher target specificity, lower toxicity, and elongate circulation time and 
controlled drug release.  
 
Administration route and mode of action determines the liposomal properties that are 
preferred for the drug-delivery. In the systemic bloodstream, for instance, it has been 
observed that liposomes from approximately 150-200 nm in diameter have a longer 
circulation time than the liposomes with a diameter of around 70 nm (Litzinger et al., 1994).  
 
The liposome size is not only important for systemic drug-delivery, but also for topical 
application. Verma and coworkers (2003) showed that the liposomal size was inversely 
related to the skin penetration of liposomes loaded with the hydrophilic fluorescent labeled 
compound carboxyfluorescein. They observed that a vesicle size of around 120 nm in 
diameter showed an enhanced skin penetration (Verma et al., 2003).  
 
2.2 Electrospun nanofibers 
 
2.2.1 Definition and background 
Fibers with a diameter under 1 µm are commonly referred to as nanofibers (Grafe and 
Graham, 2003). The decrease in a diameter makes the surface area very large compared to 
the volume of the fibers, and gives the fibers unique properties which make them optimal 





Electrospun nanofibers have a large variety of application fields (Fig. 7). They can for 
instance be exploited as textiles (Gibson et al., 1999), filters (Hajra et al., 2003), tissue 




Figure 7. Potential applications for electrospun nanofibers. Adapted and modified from Ramakrishna et al. (Ramakrishna et 
al., 2006) 
 
Drug release from a nanofibrous delivery system is dependent on a variety of elements like 
biocompatibility, mechanical properties, morphology and internal structure of the 
nanofibers. Nanofibers are often constructed of polymers, and preferably biodegradable 
polymers are used. Polymeric drug delivery systems have the ability to achieve the desired 
controlled-release of active drug over a long period of time (Liechty et al., 2010). 
 
2.2.2 Preparations of nanofibers – electrospinning (ES) 
A variety of nanofiber processing techniques like self-assembly (Niece et al., 2003) or phase 
separation (Liu and Ma, 2009) have been practiced to fabricate nanofibers. However, the ES 




unique opportunity to manipulate the properties such as the diameter, surface area, weight, 
density and orientation of the fibers (Širc et al., 2012). 
 
During ES, high voltage is applied to a pendent drop of a polymer solution being pumped out 
from a syringe needle (Fig. 8). The drop will get electrically charged, and a deformation of 
the drop (Taylor Cone) will appear when the voltage threshold is surpassed. An electrically 
charged jet will form and move towards the counter electrode. The solvent will evaporate on 
the way and a web of ultrathin nanofibers will be formed (Huang et al., 2003, Greiner and 
Wendorff, 2007). This method can yield fibers with a diameter ranging from just a few 
nanometers up until several micrometers (Širc et al., 2012).  
 
One can also perform ES using a melt instead of the polymer solution. Melt-electrospinning 
possesses the same general principle as for the ES of polymeric nanofibers, but what turns 
the jet into solid nanofibers is decrease in temperature, and not the evaporation of solvent 
as for polymer solutions (Lyons et al., 2004).  
 
ES is also easy to use to produce nanofibers in a large-scale and cost-effective way, thus 
convenient when it comes to manufacturing (Persano et al., 2013). This method makes it 
simple to add drugs or other important components to the fibers to achieve wanted 
characteristics. For example, growth factors can simultaneously be loaded into the 
nanofibers, thus resulting in more advanced and elegant novel nanosystems (Ignatova et al., 
2013).  
 
2.2.3 ES set-up and materials for electrospinning 
The ES set-up is very simple. It consists of a syringe with a polymer solution (or melt) and a 
metallic needle (spinneret), a high voltage power supply and a grounded collector plate (Fig. 






Figure 8. A schematic diagram of an electrospinning (ES) set-up. A pump pushes the polymer solution out of the syringe and 
through the metallic needle. The high voltage power supply forces the solution to stretch and form into nanofibers, which 
are gathered onto a grounded collector plate. 
 
The materials used for ES have to undergo strong deformations and large amounts of stress 
to be pulled into thin nanofibers. Thus, the material used has to be viscoelastic and also 
cohesive at the same time to end up as fibers at the end of the process (Huang et al., 2003).  
 
The ES process can form nanofibers from a huge range of materials like polymers, 
composites, semiconductors and ceramics. Nearly all soluble or meltable polymers with a 
sufficiently high molecular weight can be electrospun and turned into fibers if the process 
parameters are optimal (Greiner and Wendorff, 2007).  
 
2.2.4 Process parameters and possible problems related to processing 
The properties of the fibers are very much dependent on the process parameters during 
electrospinning (Li and Wang, 2013): 
- Voltage. The voltage has to be higher than the threshold voltage for charged jets to 
form the Taylor Cone. A voltage that is too low will not be sufficient to electrospin all 




an uneven jet. It has been discussed how different voltage affect the diameter of the 
nanofibers, and so far the results have been different depending on the polymer 
used; 
- Flow rate. Generally a low flow rate is recommended so that the polymer solution 
gets enough time to be polarized and so that the solvent gets enough time to 
evaporate on the way towards the collector.  Dripping will occur if the flow rate is too 
high, and problems with an unstable jet could occur if the flow rate is too low; 
- Collectors. There is a great variety of different collectors on the market, and the 
choice of a collector has also an influence on the ES process and the resulting fibers; 
- Distance between the metal needle and the collector. The distance has to be long 
enough to let the solvent get enough time to evaporate on its way towards the 
collector. If the distance is too long, beads can form on the fibers, thus an optimum 
distance is recommended (Li and Wang, 2013).  
 
2.2.5 Characterization of electrospun nanofibers 
Morphology, specific surface area, volume and porosity are all important contributions to 
determine the nanofibers properties. Characterization is an important mean to understand 
how a specific nanofiber composition would work as a drug delivery system or in other 
applications. There are many different means of characterization, some of which are 
mentioned here.  
 
Imaging methods are today widely used as a characterization method. Optical microscopy, 
TEM, SEM, and AFM are all used as frequent imaging techniques to investigate nanofibers. 
Optical microscopy is simple to use for investigating the physical appearance and quality of 
the nanofibers. It is a fast, simple and cheap imaging method, but has a limited resolution 
which makes it a problem to capture very detailed images (Širc et al., 2012).  
 
Microscopy methods like TEM, SEM and AFM are used when more detailed information is 
required. Since there are several imaging methods available which can be used for 
characterization, the best and most often used approach is to use a combination of methods 




needed, only one method could be applied. Amiraliyan and coworkers (2009) used SEM 
images to determine mean diameter of electrospun silk nanofibers. SEM images were taken, 
and approximately 100 random nanofibers were selected to calculate the average diameter 
(Amiraliyan et al., 2009). Chen and coworkers (2010) exploited TEM to verify a core-shell 
structure and AFM to examine surface properties in their coaxial electrospun nanofibers 
(Chen et al., 2010).  
 
To measure nanofiber porosity, mercury porosimetry (Ritter and Drake, 1945) can be used. 
Mercury is transferred into the sample under vacuum and the porosity is calculated from the 
mass of mercury intruded into the pores of the nanofibrous mat.   
 
Specific surface area can be determined using gas adsorption method and using a Brunauer, 
Emmett and Teller (BET) theory (Brunauer et al., 1938). The methods enable calculation of 
the specific surface area based on adsorbed gas volume on the surface of the sample (Širc et 
al., 2012).  
 
Contact angle measurement is a common way to determine the hydrophilicity of the 
nanofibrous mat. Static water contact angles are measured using a sessile drop system to 
determine in which degree the fibers repulse the water drop (Yu et al., 2011).  
 
2.2.6 Nanofibers as drug delivery system – wound healing 
As mentioned, nanofibers have numerous applications, and one of them is their use as a 
drug delivery system and/or dressing for successful wound healing. The decrease in fiber 
diameter makes the surface area very large compared to the volume of the fibers, and gives 
the fibers unique properties which make them optimal candidates for several applications, 
included wound healing (Huang et al., 2003). ES nanofibers have several other characteristics 
that favour their use in such applications including an ability to mimic the fibrillary structure 
of natural extracellular matrix, interconnecting porous structure with high permeability, and 
the ability to incorporate active pharmaceutical ingredients (Hu et al., 2014). As an example, 
the preparation of nanofibrous wound dressings consisting of silver as an antimicrobial 




and the antibacterial effect of the silver will be well contained (Rai et al., 2009). Therefore, 
this example illustrated how the use of nanotechnology and nanofibers improved the 
properties of silver important for sufficient wound healing.  
 
There are many types of wounds, but the ideal conditions for wound healing will roughly be 
the same. Wound healing is being carried out best in a moist environment, since both an 
excess as well as insufficient exudate production may prolong the wound healing (Leaper et 
al., 2012). The regenerating cells and tissue need a good circulation of oxygen as well. The 
material covering the wound should be protecting it from outside bacteria, but still be 
permeable to oxygen and moisture to optimize the healing process. The big diversity of 
wounds has resulted in many different targets in wound therapy and thus a wide assortment 
of wound dressings. A sufficient dressing should be at low cost, optimize healing conditions 
and be as comfortable as possible for the user (Boateng et al., 2008). Preferably, also 
antimicrobial agents could be included within the dressing that would decrease the 
microbial bioburden and biofilm formation (Rhoads et al., 2008, Leaper et al., 2012). It is 
important that the material used keeps the skin damp, but still enables absorption of 
moisture to prevent exudates from accumulating, because this accumulation can increase 
the chance of an infection developing  (Khil et al., 2003).  
 
Electrospun nanofiber mats have some distinctive qualities that could make them suitable 
for wound healing. Their high specific surface area and small pores makes them 
advantageous for absorbing liquid and protecting against bacteria. The materials must be 
chosen carefully to achieve these wanted effects (Khil et al., 2003, Rathinamoorthy, 2012) 
 
Core-shell structured nanofibers can be fabricated using coaxial electrospinning. The coaxial 
ES apparatus has, in contrary to the standard ES apparatus, two capillaries placed together 
coaxially. A core solution is injected through the inner needle, and a shell solution, most 
often consisting of a spinnable polymer, is injected through the outer needle (Mickova et al., 
2012). This leads to second-generation nanofibers with a core-shell structure. The core 
solution can for instance be a liposome dispersion and the system can be used for prolonged 





2.3 Combining liposomes and ES – novel methods for liposome preparation 
 
Today there are several conventional and novel methods used for liposome preparation, and 
they all have their advantages and disadvantages (Patil and Jadhav, 2014). Some of these 
new methods include ES in the process of fabrication.  
 
When a polymer with a shorter chain is used for ES, as a result an electrospray instead of the 
nanofibers will be formed as a final product. This technology has been exploited to fabricate 
liposomes loaded with naproxen (Yu et al., 2012).  
 
Song and coworkers fabricated liposomes made from hydrated electrospun fibers 
comprising PVP, PC and Fe3O4 nanoparticles. They found the liposomes to be generally well 
dispersed, stable to generation and they were able to control the vesicle size with the 
variation of Fe3O4 in the fibers (Song et al., 2014) 
 
Recently, Yu and coworkers (2011) introduced a novel strategy for using electrospun 
composite nanofibers as templates in fabricating the liposomes. They described how the 
prepared electrospun nanofibers composited of different concentrations of a polymer and a 
phospholipid, and how the liposomes self-assembled after the hydration of these fibers (Yu 











3 Aims of the study 
The main objective of the present study was two-fold: 
(i) To prepare and characterize the drug-loaded liposomes using conventional film 
hydration method and novel hydration of phospholipids deposited on 
electrospun amphiphilic nanofibers. 
(ii) To compare the relevant properties of the prepared liposomes. 
 
Together with this main goal, also an important specific aim was to prepare the amphiphilic 








4 Materials and methods 
 
4.1 Materials 
Chloramphenicol (Sigma-Aldrich, Chemie GmbH, St. Louis, USA; Lots SLBH3546V and 
120M0175V) was used as an antibiotic. Soybean phosphatidylcholine (Lipoid S-100, Lipoid 
GmbH, Ludwigshafen, Germany) was used as a basic material for preparing the liposomes. 
Polyvinylpyrrolidone, PVP (Kollidon 90F K90, BASF SE, Germany; Lot 82296056PO) was 
applied as a carrier polymer in electrospinning (ES). Rhodamine 123 (Sigma-Aldrich, Chemie 
HmbH, St. Louis, USA; Lot BCBL8890V) was used as an auto-fluorescent marker in the 
fluorescence microscopy studies. Other solvents (ethanol, 96.5 %, methanol) were of 




4.2 Preliminary tests 
 
4.2.1 Materials selection for ES of nanofibers 
The material selection for the present study was based on the original work published by Yu 
and coworkers (2011). They fabricated amphiphilic nanofibers composed of the mixture of 
PVP K60 and soy bean PC using chloroform as an organic solvent in ES. In the current study, 
an extensive number of pre-tests were carried out to find a proper composition of 
ingredients that could be used for successful ES. On the contrary to Yu et al. study (2011), 
PVP K60 was replaced with PVP K90 and EtOH was used as an organic solvent instead of 
chloroform due to its accessibility, safety and practical matters. Two different polymer 
concentrations (5% and 6% w/v PVP in EtOH) were tested for ES in order to find a polymer 
concentration that made the ES process easy to perform and gave adequate nanofibers 
(Table 1). Afterwards, different concentrations of PC (20% and 33.3%) and CAM (4% and 
20%) were added in the nanofibers to determine how this affected the nanofiber formation 
and if it was executable to prepare the fibers with these compositions.  
 
Table 1: Nanofiber compositions 
Nanofiber CAM 
(w/w% of the fibers) 
PC 
(w/w% of the fibers) 
PVP 
(w/w% of the fibers) 
nf1 - - 100 
nf2 - 20 80 
nf3 - 33.3 66.7 
nf4 4 32 64 
nf5 20 32 48 
 
 
4.2.2 Process parameters selection 
The significant process parameters (injection rate, voltage provided, size of needle etc.) of 
the ES system were varied to identify and find out which settings would give the most stable 




4.3 Preparation methods 
 
4.3.1 Preparation of electrospun amphiphilic nanofibers 
4.3.1.1 ES set-up 
The amphiphilic nanofibers were fabricated with an ESR200RD robotized ES system 
(NanoNC, Korea). The ES process was carried out using a 2.5 ml syringe with a 25G needle 
and an injection rate of 5 ml/h, provided by an automatic syringe pump. The voltage was 
varied between 10-12 kV. The distance between the needle and the collector plate was 
approximately 11 cm. The fibers were electrospun in an atmosphere of 18-20% air humidity 
and at temperatures of 22-25°C. 
 
4.3.1.2 ES protocol and experiments 
Nanofibers of five different compositions (Table 1) were fabricated for this study using the 
set-up elaborated in section 4.3.2.  
 
To prepare the solutions for ES, PVP (0.6 g) was dissolved in 96.5 % (w/v) EtOH (9.06-
9.28ml). Most of the nanofibers were made with phospholipids and the model drug, and in 
these cases the PC (0.12 g or 0.3 g) and CAM (0.0375 g or 0.125 g) were dissolved in EtOH 
before the polymer was added. The solution was pulled up in a syringe and the syringe was 
attached to the ES set-up. The voltage was adjusted during ES to keep a stable jet and avoid 
dripping.  
 
Three types of nanofibers were electrospun (Fig. 9): 
a) Polymeric nanofibers (100% PVP) 
b) Amphiphilic nanofibers (PC + PVP) 





Figure 9. Schematic representation of prepared nanofibers and their compositions; a) Polyvinylpyrrolidone K90 (PVP) is 
dissolved in ethanol (EtOH) and electrospun to form polymeric nanofibers; b) Phosphatidylcholine and PVP are dissolved in 
EtOH and electrospun to form amphiphilic nanofibers; c) Chloramphenicol (CAM), PC and PVP are dissolved in EtOH and 
electrospun to form drug-loaded amphiphilic nanofibers. EtOH will evaporate during the electrospinning process, and the 






4.3.2 Preparation of liposomes 
4.3.2.1 Preparation of fiber-hydrated liposomes (fiber-HL) 
Total of 100 mg nanofibers (nf3, nf4 or nf5) (Table 1) were hydrated with 1 ml distilled water 
and manually shaken (1-2 min) until the nanofibers were dissolved and a white and 
homogenous dispersion was obtained (Table 2) (Fig. 10). Reproducibility of the liposome 
preparation was confirmed using replicates.   
 
Table 2: Composition of the fiber-HL dispersions 
Liposome dispersion Hydrated nanofiber 
(100 mg) 
H2O (ml) CAM/PC (%) 
Fiber-HL0 nf3 1 - * 
Fiber-HL1 nf4 1-5 12,5 
Fiber-HL2 nf5 1-5 62.5 
*Liposome dispersion does not contain CAM 
 
 
Figure 10. Schematic representation of prepared liposome dispersions from hydrated nanofibers, a) Amphiphilic nanofibers 
consisting of phosphatidylcholine (PC) and polyvinylpyrrolidone (PVP) are hydrated to form empty liposomes; b) Drug-loaded 





4.3.2.2 Preparation of film-hydrated liposomes (film-HL) 
Liposomes with two different CAM-concentrations (14.3% and 62.5% CAM/PC) (Table 3) 
were prepared using the thin-film hydration method for later comparison to the fiber-HL. 
The drug:lipid ratio in the film-HL were targeted to approximately match the ratio in the 
fiber-HL (4.3.2.1) made from hydrated nf4 and nf4 (Table 1). CAM (28.6 mg or 125 mg) and 
PC (200 mg) were dissolved in EtOH (20 ml) in a round bottom flask. The EtOH was 
evaporated using a rotary evaporator for 20 min at 150 mbar (45 °C and 80 rpm), and 
subsequently for 1 h at 50 mbar (45 °C and 80 rpm). The time period was extended if 
needed. After the thin lipid film was dry, 10 ml of distilled water was added and the round 
bottom flask and its contents were manually shaken for approximately 20 min. Vortex was 
used if needed. Reproducibility of the liposome preparation method was confirmed using 
replicates (n=2). 
 
Table 3: Composition of the film-hydrated liposome (film-HL) dispersions 
Liposome dispersion CAM (mg) PC (mg) H2O (ml) CAM/PC (%) 
Film-HL1 28.6 200 10 14.3 
Film-HL2 125 200 10 62.5 
 
4.4 Characterization of electrospun amphiphilic nanofibers  
 
4.4.1 Optical microscopy 
The electrospun nanofibers (4.3.1) were magnified and imaged using a optical microscope 
CETI MAGTEX (Medline Sci.). 
 
4.4.2 Scanning electron microscopy (SEM) 
Samples of the electrospun nanofibers nf1-4 (4.3.1) were magnified and imaged using a 
high-resolution scanning electron microscope (SEM, Zeiss EVO MA, Germany). Both the 




mounted on aluminum stubs with silver paint and magnetron sputter coated with a 3-nm 
gold layer in argon atmosphere prior to SEM microscopy.   
 
4.5 Characterization of fiber-hydrated (fiber-HL) and film-hydrated 
liposomes (film-HL) 
 
4.5.1 Ultracentrifugation of liposome dispersions 
To further characterize and compare differently prepared liposomes using fluorescence 
microscopy and high-performance liquid chromatography (HPLC), the liposome dispersions 
(fiber-HL1-2 and film-HL1-2) were centrifuged in a Beckman Coulter ultracentrifuge with a 
SW55 Rotor at 55 000 rpm (for 1 h at 4 °C) to prepare more concentrated dispersions.  
 
Since the work was performed in different laboratories, the liposome dispersions to be 
characterized by the PCS method were centrifuged in a Beckman Optima LE-80K with a 
SW50.1 rotor at 50 000 rpm (for 1 h at 4 °C). 
 
4.5.2 Optical microscopy 
Concentrated and not concentrated dispersions of the fiber-HL (4.3.2.1) were magnified and 
imaged using a optical microscope CETI MAGTEX (Medline Sci.). The concentrated fiber-HL 
was made by self-deposition in a vacuum for 10 min.  
 
4.5.3 Fluorescence microscopy  
Fluorescence microscopy was used to visualize the liposomes and investigate their 
morphology. For liposome imaging, rhodamine 123 (0.0010 g) was dissolved in distilled 





4.5.3.1 Film-HL fluorescence microscopy 
Liposome dispersion (5 ml) (film-HL1 and film-HL2) was centrifuged (4.5.1). Liposome pellet 
was resuspended in a rhodamine 123 solution (1 ml) and incubated for at least 1 h before 
imaging with Fluorescence Microscope System (DM 5500 B, Leica Microsystems).  
 
4.5.3.2 Fiber-HL fluorescence microscopy 
Total 75 mg nanofibers (nf4 and nf5) (Table 1) were hydrated with 1 ml rhodamine 123 
solution, incubated at least for 1 h at room temperature and imaged with Fluorescence 
Microscope System (DM 5500 B, Leica Microsystems). 
 
 
Figure 11. Picture of rhodamine 123 solution used for labelling of the liposomes 
 
4.5.4 Particle size analysis – photon correlation spectroscopy (PCS) 
The PCS method was used to analyze the particle size and particle size distribution of the 
liposomes. The preparation of the samples was performed in a laminar flow cabined to 
prevent contamination. The test tubes were put in distilled water and sonicated for 10 min 
in an ultrasonic bath to remove the dust particles before use, and subsequently they were 
put in the laminar flow cabinet and washed with distilled and freshly filtered water. One 
small drop of film-HL (4.3.2.2) or fiber-HL (4.3.2.2) was added to the tube before being 
diluted with distilled and freshly filtered water. The sample was diluted until the particle 
count on the display of the instrument was within the range of 250-350 KHz (Ingebrigtsen 




were performed in triplicates. Each liposome dispersion was analyzed 3 times in 
measurement cycles of 10 min. To prevent any possible interference with the results, the 
fiber-HL was ultracentrifuged (4.5.1) before PCS analysis and the supernatant containing 
polymer was removed.  
 
All measurements were performed on the PCS instrument Nicomp submicron particle 
analyzer model 380, Nicomp Inst Corp.  
 
4.5.5 Drug encapsulation efficiency – high-performance liquid chromatography (HPLC) 
Film-HL (4.3.2.2) (5 ml) and fiber-HL (4.3.2.1) (5 ml) were ultracentrifuged (4.5.1). Both 
supernatant and pellet were analyzed by HPLC. The mobile phase consisted of 20% 
phosphoric acid, 100% methanol (MeOH) and water in the ratio of 5:40:55. The detector 
wavelength was set to 275 nm and a C18 standard column was used. The sample was diluted 
in MeOH prior to analysis. All measurements were performed in duplicates.  
 




Wpellet = amount of CAM in the pellet 
Wtotal = amount of CAM in the whole sample (supernatant + pellet) 
 
4.6 Data analysis 
4.6.1 Diameter measurement of nanofibers 
The SEM-images (4.4.2) were analyzed using the image processing computer program 
ImageJ to calculate a diameter mean of each of the fiber compositions. The bar scale was 
used to calibrate the computer program, and diameters of randomly measured 100 





4.6.2 PCS results interpretations 
4.6.2.1 For Gaussian distribution 
A Gaussian distribution mode was applied for measurements where the value for Chi-
squared did not exceed 3.00 (Ingebrigtsen and Brandl, 2002). A mean value was calculated 
for such samples.  
4.6.2.2 For Nicomb distribution 
A Nicomb distribution mode was applied for measurements where the value for Chi-squared 
exceeded 3.00 (Ingebrigtsen and Brandl, 2002). One measurement from each of the 
analyzed liposome dispersions (with Chi-sq>3) was chosen as a representative and the 
results were presented in tables.  
 
Intensity weighted distribution was used for both Gaussian and Nicomb distribution.  
4.6.2.3 Statistical evaluations 
When applicable, calculation of mean, standard deviation and t-test were performed using 




5 Results and discussion 
5.1 Characterization of electrospun amphiphilic nanofibers 
5.1.1 Optical microscopy of nanofibers 
Optical microscopy images of aluminum foil and nf1-nf3 (Table 1) are shown in Figure 12. 
The images show that nanofibers consisting of 100% PVP (b), 20% PC/80% PVP (c) and 33.3% 
PC/66.7% PVP (d) were successfully electrospun without any visible defects. It has been 
reported that the processing defects (beads) may be present when the processing conditions 
and/or the solvent properties are not optimized (Fong et al., 1999). Therefore, it can be 
concluded that the viscosity and surface tension of the polymer solution was close to 
optimal.  
 Aluminum foil was imaged separately (Fig. 12a) to help to interpret the results and so that 
this background could be distinguished from nanofibers. All the nanofibers were electrospun 
and collected on aluminum foil, and the presence of foil is still visible due to thin-layer 
nanofibers (Fig. 12b).  
 
 
Figure 12. Optical microscopy images showing aluminum foil (background) and the morphology and structure of three 
different composite nanofibers; a) Aluminum foil (X50), blue  filter; b) nf1 (X50), yellow filter, scale bar in top left corner 




5.1.2 Scanning electron microscopy (SEM) 
SEM micrographs of the amphiphilic nanofibers nf1-nf4 (Table 1) are shown in Figure 13. The 
micrographs show a nonwoven pattern, a smooth surface and an absence of beads in all of 
the investigated nanofibers – thus verifying the optical microscopy results.  
 
There is no visible dissimilarity detectable regarding the surface topography or geometric 




Figure 13. The morphology and structure of prepared electrospun nanofibers. Scanning electron microscopy (SEM) 
micrographs showing amphiphilic nanofibers of four different compositions; a) 100% polyvinylpyrrolidone (PVP) (nf1); b) 
20% phosphatidylcholine (PC) and 80% PVP (nf2); c) 33.3% PC and 66.7% PVP (nf3); d) 4% chloramphenicol (CAM), 32% PC 
and 64% PVP (nf4). Scale bars in bottom left corners corresponds to 2 µm. 
 
It has been shown that the morphology of nanofibers change from the straight and defect-
free fibers to nanofibers with defects and beads if the applied voltage during ES is too high 




with and without model drug CAM were both successfully electrospun, and that the ES 
processing parameters were optimal.  
Casper and coworkers showed that ES in an atmosphere of less than 25 % air humidity 
yielded smooth polystyrene nanofibers without any surface features, while an increase of air 
humidity caused an increase in the number of pores on the surface (Casper et al., 2004). The 
nanofibers in this current study were electrospun in an atmosphere of 18-20% air humidity 
and showed no visible pores on the surface.  
5.1.3 Diameter measurement of nanofibers 
One of the most important characteristic of nanofibers is their mean diameter. This 
parameter enables understanding of the quality and performance of these nanofibers. Since 
in the present project, different nanofiber compositions were used, it was of interest to 
compare these nanofibers and their morphology. The mean values of nanofiber diameter 
were calculated by analyzing the SEM micrographs (5.1.2), and are shown with 
corresponding standard deviation (SD) in Figure 14. 
 
 
Figure 14. Diameter of four different nanofiber compositions (nf1-nf4). The values denote the mean of diameter (nm) ± SD 





















nf1*                nf2                   nf3**              nf4  
nf1 (100 % PVP)
nf2 (20 % PC, 80 % PVP)
nf3 (33.3 % PC, 66.7 % PVP)
nf4 (4 % CAM, 32 % PC, 64 % PVP)
659 ± 123 
722 ± 166 
845 ± 136 





Pure PVP nanofibers (nf1) from a 6% EtOH solution showed a mean diameter of 659 ± 123 
nm. The diameter of the fibers increased when PC was added (nf2 and nf3), but possibly 
decreased when CAM was one of the components (nf4).  
 
A statistical analysis shows that there is a significant difference between the diameters of 
nf1 and nf3 (p<0.01) and between nf1 and nf4 (p<0.01), but no significant difference 
between nf3 and nf4. Thus, the results imply that the presence of PC affects the morphology 
of the nanofibers, but the addition of 4% CAM into the formulation does not change the 
morphology of the nanofibers. It should be mentioned that the reproducibility of the ES was 
verified by using triplicate measurements. Most likely, in the present study, the processing 
conditions were optimized to reproduce the results.    
 
Yu and coworkers (2011) observed the diameter of their amphiphilic nanofibers (consisting 
of PVP K60 and PC, with chloroform as solvent) decreasing when consisting of 20% and 
33.3% PC compared to 100% PVP nanofibers. The same phenomenon was not observed in 
the present study. A variety of elements such as temperature, air humidity, polymer and 
organic solvent could have an influence on the fiber morphology (Li and Wang, 2013, Mit‐
uppatham et al., 2004). It has been shown that by varying the polymer concentration the 
solution viscosity may change, and the solution viscosity is directly linked to the nanofiber 
diameter and electrospinnability of the polymer solution (Fong et al., 1999, Hu et al., 2014). 
Most likely in the present study the addition of PC increased the nanofiber diameter due to 
increased viscosity in the solution. The morphology and diameter of electrospun nanofibers 
depend largely on the intrinsic properties of the solution, type of polymer, conformation of 






5.2 Characterization of fiber-hydrated and film-hydrated liposomes 
 
5.2.1 Optical microscopy of fiber-HL  
Due to a novelty of the liposome preparation method, the liposome self-assembly from 
electrospun nanofibers was controlled in situ and imaged using optical microscopy. Two 
fiber-HL dispersions without drug (pure polymer and PC) were prepared and investigated 
under the microscope. The images are shown in Figure 15. The images display how the 
liposomes have a tendency to agglomerate in very concentrated dispersions.  
 
The optical microscopy has its limitations, and can only magnify by X50. The liposomes which 
can be seen in this type of microscope are only the vey largest vesicles. In more 
concentrated dispersions where the liposomes agglomerate (Fig. 15b-c), it is easier to 
observe these nanostructures. However, the results showed that this preparation method 
(fiber-hydration) can be used for liposome preparation and was used further for preparing 
the drug-loaded liposome formulations.  
 
 
Figure 15. Optical microscopy images showing the liposomes self-assembled from hydrated nanofibers; a) 50 mg nf2 + 5 ml 
H2O (X50), yellow filter, scale bar corresponds to 10µm; b)  100 mg nf2 + 1 ml H2O + vacuum for 10 min (X20), yellow filter, 
scale bar corresponds to 20 µm; c) 100 mg nf2 + 1 ml H2O + vacuum for 10 min (X50), red filter, scale bar corresponds to 10 
µm. 
 
5.2.2 Fluorescence microscopy of fiber-HL and film-HL 
Different analytical and technological methods can be used to characterize the liposomes 
(Ruozi et al., 2011). Among others, well-known microscopic techniques have been used and 
their applicability in investigating the morphology of the liposome proven. Fluorescence 
microscopy images of fiber-HL1-2 and film-HL1-2 (Table 2) are shown in Figure 16. It is 




can be seen that most likely the polymer itself present in samples a-b has picked up some of 
the rhodamine coloring. There is a lot of noise in these images and this makes it difficult to 
interpret the results using this analyzing method. It is hypothesized that this experiment 
could be used together with an ultracentrifugation step during the preparation of the 
rhodamine-labelled samples to remove the polymer and any other possible disturbance 
from the samples during the analyses of the liposomes. It has been reported previously that 
the sample preparation is a critical step during the characterization of nanosized liposomes, 
however the CLSM together with labelling has shown good potential  (Ruozi et al., 2011). 
 
 
Figure 16. Fluorescence microscopy images of rhodamine-labelled liposomes; a) fiber-HL1; b) fiber-HL2; c) film-HL1; d) film-







5.2.3 Particle size analysis 
The morphology of the liposomes was investigated using microscopy, but the size and size 
distribution of the liposomes were further investigated using PCS. To investigate the 
diameter of the liposomes, four dispersions (film-HL1-2 and fiber-HL1-2) which included 
three parallels each (12 samples in total) were analyzed using PCS. Only the formulations 
that included drug were tested. As an example, PCS analysis graphs with lower CAM 
concentration are shown both for fiber- and film-HL (Fig. 17 and Fig. 18, respectfully).  
 
Control measurements were performed with only pure polymer and PC consisting (without 




Figure 17. Example of a PCS measurement for fiber-HL1. The graph shows that two populations of different vesicle size were 





Figure 18. Example of a PCS measurement for film-HL1. The graph shows that the diameter size of the vesicles in the 
liposome dispersion is outside the range of the instrument. 
 
The PCS analysis showed that the preparation technique through hydration of nf4 (fiber-
HL1) yielded a polydisperse distribution with two populations. One representative 
measurement was chosen to represent the batch (Fig. 19 and Table 4). The largest 
percentage of the vesicles in this sample (61.5%) had a mean diameter of 671.3 ± 91.0 while 
a smaller percentage (38.5%) of the liposomes had the diameter 110.3 ± 12.7, as shown in 








Figure 19. The measurement which was chosen to represent the measurements for fiber-HL1. The sample was 
polydispersed, and the graph shows the two populations detected.  
  
Table 4: Vesicle diameter for the three liposome series which were polydisperse 
Sample Peak 1 (nm) % of 
dispersion 
Peak 2 (nm) % of 
dispersion 
Comment 
Film-HL1 - - - - Out of range* 
Film-HL2 - - - - Out of range* 
Fiber-HL1 110.3 ± 12.7 38.5 671.3 ± 91.0 61.5 - 
*The value was out of the instruments analysis range 
 
The hydrated nf5 (film-HL2) yielded a monodisperse population, and is therefore not 
included in Table 4. A Gaussian distribution showed an average of the mean diameter of 






Figure 20. One of the measurements for fiber-HL2. The graph shows a monodisperse distribution of vesicle sizes in the 
dispersion.  
 
The measurements from both of the film-HL were all outside the range of the PCS 
instrument (Table 4). It is reasonable to assume that these vesicles’ diameters are too large 
to be measured (>800 nm) since it is common that self-assembled liposomes from a 
hydrated thin-lipid film yields a population of MLV’s (2.1.5.1 and Fig. 4).  
 
Film-HL1-2 showed a polydisperse distribution (Table 4).  Since sizes of both of the film-HL’s 
were outside the range of the instrument, it is not certain if they actually were polydisperse 
or not.  
 
If a few larger particles are present in a sample for PCS analysis, the instrument tends to 
overlook very small vesicles below 30 nm (Ingebrigtsen and Brandl, 2002). This will often be 
the case for self-assembled liposome dispersions which has not been size reduced. In other 
words, there might be some very small vesicles present in the samples which have been 
neglected by the analyzing instrument. In the present study, it was of interest to investigate 




how the liposomes naturally formed. For future experiments, it would be interesting to see if 
the fiber-HL’s respond to size reduction in the same manner as film-HL’s.  
 
5.2.4 Drug encapsulation efficiency 
The entrapment efficiency was determined to compare the encapsulation of drug in 
liposomes prepared by different methods. Both film-HL1-2 and fiber-HL1-2 samples were 
analyzed using HPLC analysis. The results are presented in Figure 21.  A statistical analysis 
shows that there is a significant difference between the encapsulation efficiency of film-HL1 
and fiber-HL1 (p<0.01) and between film-HL2 and fiber-HL2 (p=0.01). 
 
 
Figure 21. Drug encapsulation efficiency of film-HL1-2 and fiber-HL1-2. The values denote the mean of drug encapsulation 
efficiency (%) ± SD (n=2-3). *Film-HL1 shows a significant difference from fiber-HL1 (p<0.01). **Film-HL2 shows a significant 
difference from fiber-HL2 (p=0.01).  
 
The fiber-HL1, containing the lower amount of CAM, had a drug encapsulation efficiency of 
26.1 ± 2.9, while the fiber-HL2, containing the higher amount of CAM, had a drug 
encapsulation efficiency of 15.1 ± 0.1 (Fig. 21). Even though the drug encapsulation 
efficiency was higher for the fiber-HL1 dispersion, a greater amount of CAM (mg) was 
detected in the pellet of the centrifuged samples (2.9 mg compared to 1.0 mg) (Table 5).  In 
conclusion, a higher percentage of CAM is encapsulated in the liposomes when the fiber-HL1 
58,63 ± 3.31 
26,10 ± 2.94 
45,42 ± 0.88 

































self-assemble, but a greater mass of CAM is encapsulated in the liposomes when fiber-HL2 
self-assemble.  
 





CAM in pellet 
(mg) 
Total (mg) Theoretical 
amount of 
CAM (mg) 




5.4 7.6 12.9 14.3 90.2 ± 5.9 
Film-HL2 
n=2 
22.7 18.8 41.5 62.5 66.4 ± 0.5 
Fiber-HL1 
n=3 
2.9 1.0 3.8 4.0 95.8 ± 1.7 
Fiber-HL2 
n=3 
16.5 2.9 19.4 20.0 97.0 ± 1.3 
The values denote the mean for the mass of CAM and mean ± SD for CAM (% of initial).  
 
A noticeable large amount of CAM was lost during the fabrication of film-HL2 (Table 5). The 
HPLC results showed that only 66.4 % of the initial CAM amount was present within the 
liposome dispersion. This loss is most likely due to the poor water solubility of CAM. The 
thin-lipid film prepared for the film-HL2 dispersion contained 125 mg CAM, and the film was 
dispersed in 10 ml water. CAM is soluble in water 2.5 mg/ml (25°C) (The Merck Index, 2013), 
thus the loss of CAM can be explained with an insufficient dissolution of CAM. This could 
affect the drug amount which is captured inside the vesicles and this in turn could affect the 
drug encapsulation efficiency and the vesicle size. However, the drug encapsulation 
efficiency was determined using the real mass of CAM in the sample, and not the theoretical 
amount.  
 
This CAM solubility issue and consequent problem was not present when fabricating the 
fiber-HL. This is because the fibers (100 mg) contained 4mg or 20 mg of CAM, and they were 





It is fair to assume that a loss of CAM happened during the preparation of the film-HL for the 
particle size analysis (5.2.3) as well, and this could have an impact on the size of the vesicles 
assembled. This would not be detectable on the results in this study due to the fact the all of 
the particle size measurements for the film-HL were outside the range of the measuring 
instrument. The same phenomenon was observed for the film-HL dispersions.  
 
The PCS analysis suggest that the mean diameter of the fiber-HL vesicles is significantly 
smaller than the film-HL vesicles, and this can explain why the drug encapsulation efficiency 
is significantly smaller for the fiber-HL. It is natural to assume that the vesicles are not able 
to capture as much drug because of their reduced size, and thus reduced carrying space for a 
drug. Previously it has been shown that the liposome encapsulation efficiency is greatly 
dependent on the vesicle size and the lamellarity of the liposomes (Betageri and Parsons, 
1992, Vemuri and Rhodes, 1995).  Berger et al. (2001) fabricated drug-loaded liposomes of 
different sizes using filer-extruders, and found that the encapsulation efficiency correlated 
quite well with the sizes of the liposomes (Berger et al., 2001).  
 
5.3 Comparison of fiber-HL and film-HL preparation methods and the 
prepared liposomes 
 
Physiochemical analysis data generated in the present study allowed comparison of the 
drug-loaded liposomes prepared by conventional film-hydration method with drug-loaded 
liposomes prepared by nanofiber hydrated method. Liposomes prepared by different 
methods were compared for their entrapment efficiency, vesicle size and polydispersity. In 
both methods, the liposomes self-assembled during hydration phase, but the results 
confirmed that the liposome formation mechanism differs. Regardless of the preparation 
method used, both methods allowed preparation of drug-loaded liposomes. However, the 
mean diameters of liposomes differed considerably as well as the entrapment efficiency. 
Both the microscopy and PSC showed that formed liposomes were statistically different 
from each other. The fiber-hydrated liposomes showed a polydispersity with the lower CAM 
concentration, and monodispersity with a higher CAM concentration. Further investigation 
needs to be done to determine how the CAM concentration and other nanofiber 




The shelf life of the liposomes is one of the biggest challenges when it comes to liposome 
applications. A pharmaceutical delivery system has to be physically stable, and not interfere 
with the chemical properties of the drug, otherwise it will not work in a proper or 
predictable manner (Vemuri and Rhodes, 1995). Yu and coworkers suggested that the pre-
product of the fiber-hydrated liposomes, the solid amphiphilic nanofibers, could be used to 
store «frozen» liposomes (Yu et al., 2011). This present study has shown that drug-loaded 
liposomes also can be prepared using this novel method. It opens the opportunity to store 
amphiphilic nanofibers containing drug, and hydrate the nanofibers right before use to self-
assemble the liposomes. Most likely a smaller liposome vesicle size could be achieved 
without any additional extrusion step. How the different nanofiber compositions affect the 
assembling and size of the liposomes and the stability of both nanofibers and liposomes 







It was possible to prepare the drug-loaded liposomes in situ using the hydration of 
phospholipids deposited on the electrospun amphiphilic nanofibers. Electrospinning (ES) was 
found to be a suitable method for preparing amphiphilic nanofibers. Bead-free nanofibers 
with a smooth surface and a diameter ranging from 659 to 818 nm were successfully 
produced by means of ES. Microscopic techniques as well as photon correlation 
spectroscopy allowed performing liposome physicochemical characterization. High-
performance liquid chromatography (HPLC) results showed drug encapsulation efficiency. 
The self-assembled liposomes made from hydrated amphiphilic nanofibers showed a lower 
drug encapsulation efficiency compared to film-hydrated liposomes. The liposome 
dispersion made from hydrated amphiphilic nanofibers showed an overall smaller vesicle 
size, and monodispersity when the drug amount was increased. The present nanotechnology 
self-assembly approach opens up new options for the fabrication, stabilization and delivery 















- Short-term and long-term stability studies of both the nanofibers and liposomes to 
determine the optimal storage conditions. Could the polymer have an influence on 
the liposome stability due to increased viscosity of the dispersion? 
- To test and compare the lamellarity of liposomes. Testing of other concentrations of 
drug and phospholipid. What is the ideal composition of the nanofibers prior to 
hydrating? How does the drug affect the assembly and characteristics such as vesicle 




- Drug release studies for nanofibers prior to hydrating and fiber-hydrated liposomes 
- Incorporating both film-hydrated and fiber-hydrated liposomes into nanofibers using 
a coaxial electrospinning (ES) set-up and eventually comparing the relevant 
properties. 
- To map out the drug-release profile for nanofibers. How will the drug-release profile 
for the drug-loaded amphiphilic nanofibers differ from drug-loaded nanofibers 
without phospholipids? 
- Evaluating applications of the drug-loaded amphiphilic nanofibers. Could nanofibers 
be used as an intermediate product for liposomes which are hydrated prior to use? 
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PURPOSE 
The objective of the present study was to develop and evaluate the electrospun amphiphilic nanofibers 
intended for templating and preparing drug-loaded liposomes. The present approach exploits the hydration of 
phospholipids deposited on electrospun nanofibers for the formation of liposomes.  
INTRODUCTION  
The physical stability is the primary challenge in formulating liposomes for drug delivery applications.  A novel 
strategy for using electrospun composite nanofibers as templates in fabricating liposomes was recently 
introduced by Yu et al. (1). To date, this strategy has not been applied for fabricating drug-loaded liposomes.    
METHODS  
The amphiphilic nanofibers were prepared using a ESR200RD robotized electrospinning system (NanoNC, 
Korea). A conventional film hydration method was used as a reference method for preparing liposomes. 
Polyvinylpyrrolidone (PVP 90) and soybean phosphatidyl choline were used at different concentrations as a 
filament-forming matrix. The liposome formation were monitored in situ by using optical microscopy. The 
geometric properties and surface topography of nanofibers were characterized by scanning electron 
microscopy (SEM). The physical solid-state analyses were made by Raman spectroscopy, X-ray powder 
diffraction (XPRD) and differential scanning calorimetry (DSC).  
RESULTS 
Electrospinning of phospholipids (soybean phosphatidyl choline) with PVP using ethanol as a solvent system 
was found to be successful in fabricating amphiphilic composite nanofibers. According to the optical 
microscopy results, the immediate hydration of phospholipids deposited on the amphiphilic nanofibers 
occurred within few seconds resulting in the formation of liposomes in water. The formation of liposomes were 
studied in both concentrated and diluted solutions, and the liposomes appeared to aggregate more readily in 
the concentrated solutions than in the diluted solutions.   
CONCLUSION 
It is possible to prepare liposomes in situ using the hydration of phospholipids deposited on  electrospun 
amphiphilic nanofibers. The present nanotechnology self-assembly approach opens up new alternatives for the 
fabrication, stabilization and delivery of liposomes. 
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9.2 SEM micrographs 
 
 
Figure 22: The morphology and structure of prepared electrospun nanofibers. Scanning electron microscopy (SEM) 
micrographs showing amphiphilic nanofibers of four different compositions; a) 100% polyvinylpyrrolidone (PVP) (nf1); b) 
20% phosphatidylcholine (PC) and 80% PVP (nf2); c) 33.3% PC and 66.7% PVP (nf3); d) 4% chloramphenicol (CAM), 32% PC 
and 64% PVP (nf4). Scale bars in bottom left corners corresponds to 10 µm. 
